Dr Reddy’s gets positive CHMP opinion from EMA for its proposed Rituximab biosimilar
NE BUSINESS BUREAU HYDERABAD, JULY 29 Dr Reddy’s Laboratories Ltd on Monday announced that the European Medicines Agency’s (EMA) Committee ...
Tag: Dr. Reddy’s
Dr Reddy’s signs non-exclusive patent licensing pact with Takeda to commercialise Vonoprazan
NE HEALTH BUREAU HYDERABAD JULY 18 Dr Reddy’s Laboratories Ltd. on Thursday announced that it has entered into a non-exclusive ...
Alvotech and Dr. Reddy’s collaborates for commercialization of AVT03 (denosumab) in U.S., Europe & UK
NE HEALTH BUREAU HYDERABAD/REYKJAVIK (ICELAND), MAY 21 Alvotech, a global biotech company specializing in the development and manufacture of biosimilar ...
Q4 Results: Dr. Reddy’s net proft up 36.3 pc at Rs 1,307 crore
NE BUSINESS BUREAU HYDERABAD, MAY 7 Dr Reddy’s Laboratories Ltd. on Tuesday announced its consolidated financial results for the fourth ...
In a first, Dr. Reddy’s launches Condition Management programme ‘DailyBloom IBS’
NE HEALTH BUREAU HYDERABAD, APRIL 21 Dr Reddy’s Laboratories Ltd on Friday announced the roll-out of its condition management programme ...
Bayer and Dr Reddy’s sign a marketing and distribution pact for second brand of Vericiguat in India
NE HEALTH BUREAU HYDERABAD APRIL 5 Dr Reddy’s Laboratories Ltd. and Bayer on Friday announced that both companies have ...
Eli Lilly inks voluntary licensing pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy’s, MSN Labs
NE BUSINESS BUREAU NEW DELHI, MAY 13 Drug firm Eli Lilly and Company on Thursday said it has inked voluntary ...
Dr Reddy’s ADRs list on NSE IFSC
NE BUSINESS BUREAU NEW DELHI, DEC 9 NSE International Exchange (NSE IFSC) has become the first international bourse in GIFT ...
Modi to interact with 3 teams involved in developing COVID vaccine
NE NEWS SERVICE NEW DELHI, NOV 29 Prime Minister Narendra Modi will interact with three teams involved in developing COVID-19 ...
